Bifidobacterium longum (Bl-05)
Introduction to Bifidobacteria Metabolism
Bifidobacterium longum Bl-05 is a Gram-positive, anaerobic, branched rod-shaped bacterium belonging to the Actinobacteria phylum. As a chemoorganotroph, it relies on the fermentation of complex carbohydrates that escape digestion in the upper gastrointestinal tract. Unlike many other lactic acid bacteria that utilize the homofermentative or heterofermentative glycolysis pathways, Bifidobacteria utilize a unique hexose metabolism pathway known as the 'bifid shunt' or the fructose-6-phosphate phosphoketolase pathway. This pathway is characterized by the presence of the enzyme fructose-6-phosphate phosphoketolase (F6PPK), which serves as a taxonomic marker for the genus. The bifid shunt is highly efficient, yielding more ATP per mole of glucose compared to traditional lactic acid fermentation, and results in the production of acetate and lactate in a theoretical molar ratio of 3:2. These organic acids are critical for lowering the luminal pH of the colon, creating a microenvironment that is hostile to acid-sensitive pathogenic bacteria such as Enterobacteriaceae and Clostridia.
Gastrointestinal Transit and Survivability
For a probiotic strain to exert physiological benefits, it must survive the harsh physicochemical barriers of the upper gastrointestinal tract, primarily gastric acidity and bile salt toxicity. B. longum Bl-05 exhibits robust intrinsic resistance mechanisms. Its survival in low pH environments is mediated by the upregulation of F0F1-ATPase, a proton pump that extrudes intracellular protons at the expense of ATP, thereby maintaining intracellular pH homeostasis. Furthermore, Bl-05 produces specific exopolysaccharides (EPS), which form a protective capsular layer around the bacterial cell wall. This EPS layer not only shields the bacterium from enzymatic degradation and acid stress but also facilitates adhesion to the intestinal mucosa. Resistance to bile salts is conferred by the expression of bile salt hydrolase (BSH) enzymes. BSH catalyzes the deconjugation of glycine- or taurine-conjugated bile acids into free bile acids and amino acids. Deconjugated bile acids are less soluble and less toxic to the bacterial cell membrane, allowing Bl-05 to proliferate in the bile-rich environment of the duodenum and jejunum.
Competitive Exclusion and Antimicrobial Activity
Once Bl-05 reaches the colon, it engages in competitive exclusion, a process by which it prevents the colonization and proliferation of opportunistic pathogens. This is achieved through several synergistic mechanisms. First, Bl-05 competes for limited adhesion sites on the intestinal epithelial cells and the overlying mucus layer. By occupying these niches, it physically blocks pathogens from attaching and initiating infection. Second, Bl-05 competes for essential nutrients, particularly complex oligosaccharides. Its genome encodes a diverse array of glycosyl hydrolases, enabling it to efficiently forage on host-derived glycans (such as mucin) and dietary prebiotics. Third, the production of SCFAs (acetate and lactate) not only lowers the pH but also exerts direct antimicrobial effects. In their undissociated form, these organic acids can penetrate the lipid bilayer of pathogenic bacteria. Once inside the neutral cytoplasm of the pathogen, the acids dissociate, releasing protons that disrupt intracellular pH and metabolic functions. Additionally, some strains of B. longum are known to produce bacteriocins or bacteriocin-like inhibitory substances (BLIS), which are ribosomally synthesized antimicrobial peptides that form pores in the membranes of closely related target bacteria.
Immunomodulation and Gut Barrier Enhancement
The interaction between B. longum Bl-05 and the host immune system is a highly orchestrated process mediated by the gut-associated lymphoid tissue (GALT). The bacterial cell wall components, including peptidoglycan, lipoteichoic acid, and EPS, act as microbe-associated molecular patterns (MAMPs). These MAMPs are recognized by pattern recognition receptors (PRRs), such as Toll-like receptors (TLRs) and nucleotide-binding oligomerization domain-like receptors (NLRs), expressed on the surface of intestinal epithelial cells and resident antigen-presenting cells (APCs) like dendritic cells. The binding of Bl-05 to TLR2 and TLR4 on dendritic cells triggers intracellular signaling cascades, predominantly via the NF-κB and MAPK pathways. This interaction typically promotes a tolerogenic immune response, characterized by the maturation of dendritic cells that drive the differentiation of naive T cells into regulatory T cells (Tregs). Tregs secrete anti-inflammatory cytokines, notably Interleukin-10 (IL-10) and Transforming Growth Factor-beta (TGF-β), which suppress excessive inflammatory responses and maintain intestinal immune homeostasis. Furthermore, Bl-05 enhances the integrity of the intestinal epithelial barrier. It upregulates the expression and promotes the correct apical localization of tight junction proteins, such as zonula occludens-1 (ZO-1), occludin, and claudins. By reinforcing the tight junctions, Bl-05 reduces paracellular permeability, thereby preventing the translocation of luminal antigens, endotoxins (like lipopolysaccharide, LPS), and pathogens into the systemic circulation—a condition often referred to as 'leaky gut' or metabolic endotoxemia.
What are the benefits of Bifidobacterium longum BL 05? +
Who should not take Bifidobacterium longum? +
Which Align probiotic is best for IBS? +
Which probiotic is best for sibo? +
Are there any medications you can't take with probiotics? +
Who should not take Align? +
Can I take probiotics if I have sibo? +
What is the difference between B. longum and Bl-05? +
How many CFUs of Bl-05 should I take? +
Does Bl-05 need to be refrigerated? +
Can Bl-05 survive stomach acid? +
Is Bl-05 safe for daily use? +
How long does it take for Bl-05 to work? +
Does Bl-05 cause gas and bloating? +
Is Bl-05 dairy-free and gluten-free? +
Everything About Bifidobacterium longum (Bl-05) Article
Introduction to Bifidobacterium longum Bl-05 Bifidobacterium longum Bl-05 is a highly specialized, proprietary strain of probiotic bacteria that plays a crucial role in maintaining human gastrointestinal health. Belonging to the Bifidobacteria genus—which are among the first colonizers of the human infant gut—B. longum is naturally found in the large intestine. The Bl-05 strain in particular is utilized in premium dietary supplements and functional foods due to its Generally Recognized As Safe (GRAS) status by the FDA and its proven ability to survive the harsh journey through the digestive tract. Unlike generic probiotics, strain-specific variants like Bl-05 are cultivated for precise physiological functions, primarily focusing on immune modulation, competitive exclusion of pathogens, and the enhancement of the intestinal mucosal barrier.
The Experience: What to Expect When beginning a regimen with Bifidobacterium longum Bl-05, it is important to manage expectations regarding the timeline of effects. Probiotics are not acute therapeutics; they do not provide immediate relief like an antacid or a stimulant.
During the first few days of supplementation, you may actually experience a mild increase in gas or bloating. This is a normal physiological response known as the 'Herxheimer reaction' or simply a microbiome shift, occurring as the newly introduced Bl-05 bacteria begin to colonize the gut, ferment carbohydrates, and displace less desirable bacterial strains.
By weeks two to four, this initial adjustment period typically subsides. Users consistently report a noticeable improvement in digestive regularity, a reduction in post-meal bloating, and a general soothing of mild gastrointestinal discomfort. Because Bl-05 primarily colonizes the large intestine, its benefits are deeply tied to the final stages of digestion and the systemic immune responses governed by the gut.
Deep Dive: How Bl-05 Works in the Gut The efficacy of Bifidobacterium longum Bl-05 is rooted in its advanced biochemical mechanisms. To understand its impact, we must look at its journey and its metabolic outputs.
Surviving the Acid Bath The human stomach is a highly acidic environment designed to break down food and destroy ingested pathogens. For a probiotic to be effective, it must survive this gastric acid and the subsequent exposure to bile salts in the duodenum. Bl-05 is equipped with intrinsic resistance mechanisms, including the production of exopolysaccharides (EPS)—a protective outer layer that acts like a microscopic shield. Additionally, it expresses bile salt hydrolase enzymes that neutralize toxic bile acids, allowing the bacteria to safely transit to the colon.
The Bifid Shunt and SCFA Production Once in the anaerobic environment of the large intestine, Bl-05 begins to feed. It utilizes a unique metabolic pathway called the 'bifid shunt' to ferment complex carbohydrates (prebiotics) that our bodies cannot digest. The primary byproducts of this fermentation are short-chain fatty acids (SCFAs), specifically acetate and lactate.
These SCFAs are metabolic gold. They lower the pH of the colon, creating an acidic environment that is highly inhospitable to pathogenic bacteria like E. coli and Clostridia. Furthermore, these organic acids serve as a primary energy source for the colonocytes (the cells lining the colon), promoting cellular turnover and maintaining a healthy, robust intestinal lining.
Immune System Modulation Approximately 70% of the human immune system resides in the gut-associated lymphoid tissue (GALT). Bl-05 interacts directly with this system. The structural components of the Bl-05 cell wall are recognized by immune sensors (Toll-like receptors) on the surface of the intestinal lining. This interaction stimulates the production of regulatory T-cells (Tregs) and anti-inflammatory cytokines like Interleukin-10 (IL-10). By promoting this tolerogenic immune response, Bl-05 helps prevent the immune system from overreacting to harmless dietary antigens, thereby reducing systemic inflammation.
Clinical Evidence and Health Benefits While generic Bifidobacterium longum has been the subject of hundreds of clinical trials, the specific Bl-05 strain is supported by emerging research highlighting its safety and efficacy.
According to data from the Oasis Health database and associated literature (PMID: 31777763, PMC6520897), Bl-05 is recognized for its clinical applications in supporting digestive function. It is frequently utilized to mitigate symptoms of irritable bowel syndrome (IBS), though it is important to note that medicinal use of this product has not been approved by the FDA to treat any specific medical condition.
In multi-strain formulations, such as Allergy Research Group's BifidoBiotics, Bl-05 is dosed at 1.23 Billion CFUs alongside other synergistic strains. This specific dosing is designed to ensure that a clinically relevant number of viable bacteria reach the colon to exert their beneficial effects.
Synergies: Building the Ultimate Gut Stack Bl-05 rarely works alone. In the complex ecosystem of the microbiome, cross-feeding and synergy are essential.
Prebiotics (Inulin, FOS, GOS): Probiotics need food. Consuming Bl-05 alongside prebiotic fibers ensures the bacteria have the necessary substrates to produce SCFAs. Lactobacillus Strains: While Bifidobacteria dominate the large intestine, Lactobacillus strains (like L. acidophilus La-14 or L. rhamnosus Lr-32) dominate the small intestine. Combining Bl-05 with these strains provides comprehensive, top-to-bottom gastrointestinal support.
Safety, Side Effects, and Contraindications Bifidobacterium longum Bl-05 is generally considered safe for the vast majority of the population. However, as noted by Drugs.com, there are potential side effects and contraindications to be aware of.
Common side effects include temporary bloating or gas as the body adjusts to the supplement.
Severe allergic reactions are rare but require immediate medical attention; signs include hives, difficulty breathing, and swelling of the face, lips, tongue, or throat.
Crucially, probiotics should not be taken by individuals who are severely immunocompromised (e.g., those undergoing chemotherapy, organ transplant recipients, or those with central venous catheters) without strict medical supervision. In these vulnerable populations, there is a risk that live bacteria could translocate across the gut barrier and cause systemic infection or bacteremia. Signs of infection include fever, chills, sore throat, and unusual tiredness.
Label Literacy: Finding a Quality Bl-05 Supplement When shopping for a Bl-05 supplement, label transparency is paramount.
1. Look for the Strain: The label should explicitly state 'Bifidobacterium longum Bl-05', not just 'Bifidobacterium longum'. The strain designation (Bl-05) guarantees you are getting the specific bacteria with the properties discussed above. 2. CFU Guarantee: Ensure the product guarantees its Colony Forming Unit (CFU) count at the time of expiration, not just the time of manufacture. Probiotics are live organisms that die off over time; a reputable manufacturer accounts for this overage. 3. Storage Requirements: Pay attention to storage instructions. While many modern lyophilized (freeze-dried) strains like Bl-05 are shelf-stable, storing them tightly closed and refrigerated can help maintain maximum potency over the long term.